• FirefoxInstall the new Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.27%

    Dynavax Technologies Corporation (DVAX)

    -NasdaqCM
    22.37 Down 1.39(5.85%) Mar 26, 4:00PM EDT
    Add to Portfolio
    Prev Close:23.76
    Open:23.48
    Bid:19.02 x 100
    Ask:23.50 x 2300
    1y Target Est:38.20
    Beta:3.22
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:22.01 - 23.48
    52wk Range:12.50 - 26.89
    Volume:701,826
    Avg Vol (3m):418,625
    Market Cap:646.81M
    P/E (ttm):N/A
    EPS (ttm):-3.45
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DVAXDown 5.85%646.81M
    GSKDown 1.46%112.24B
    MRKDown 1.13%163.48B
    RHHBYDown 1.61%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):62.27
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-3.87
    Quarterly EPS Est (Mar-15) :-0.95
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback